Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Erivan-ER 37.5 Tablet

Prescription Icon
Prescription Required

Marketer

Eridanus Healthcare

Salt Composition

Venlafaxine (37.5mg)

Overview Erivan-ER 37.5 Tablet

Deprexis-XR 37.5 mg tablets treat depression and anxiety. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, unease, poor concentration, tiredness, perspiration, rapid heartbeat, and intrusive thoughts. Take Deprexis-XR 37.5 mg with food, consistently at the same time daily for stable blood levels. If a dose is missed, take it immediately upon recall. Complete the prescribed course, even with symptom improvement; abrupt cessation may worsen your condition. Common side effects may include queasiness, vomiting, sleeplessness, reduced appetite, nervousness, bowel irregularity, excessive sweating, and sexual difficulties. Dizziness and drowsiness are possible; avoid driving or tasks requiring alertness until the medication's effects are known. These side effects typically subside; consult your physician if they persist or are bothersome. Before starting Deprexis-XR 37.5 mg, disclose any kidney, heart, or liver issues, or history of seizures. Report any unusual mood or behavioral shifts, worsening depression, or suicidal thoughts to your doctor immediately.

Primary Ingredients of Erivan-ER 37.5 Tablet

No text provided. Please provide the text you would like me to rephrase.

Uses of Erivan-ER 37.5 Tablet

Mood disorders encompassing depressive and anxiety symptoms

Major Benefits of Erivan-ER 37.5 Tablet:

Follow your doctor's instructions or consult the product label for usage guidelines. Consume Erivan-ER 37.5 Tablet with a meal.

Common Side effects of Erivan-ER 37.5 Tablet:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Erivan-ER 37.5 Tablet:

Follow your physician's instructions or consult the product label for proper administration. Consume Erivan-ER 37.5 Tablet with a meal.

How Erivan-ER 37.5 Tablet works:

Erivan-ER 37.5mg tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Erivan-ER 37.5 Tablet is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Erivan-ER 37.5 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescribing. Consult your doctor for advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Erivan-ER 37.5 mg tablets while breastfeeding is potentially hazardous. Studies in humans indicate a possibility of the medication transferring to breast milk, posing a risk to the infant. Close observation of newborns for signs of lethargy and appropriate weight increase is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Erivan-ER 37.5 Tablet, due to potential side effects including dizziness, confusion, and visual disturbances like blurred vision.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Erivan-ER 37.5 mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Erivan-ER 37.5 mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Erivan-ER 37.5 Tablet :

Should you forget to take your Erivan-ER 37.5 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Erivan-ER 37.5 Tablet

LabelValue
Chemical Category Anisole-based compound
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Behavior Class SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Erivan-ER 37.5 Tablet

Sedation is a possible side effect of Erivan-ER 37.5 Tablet. Inform your doctor about any other sleep aids you're using before taking it.
Yes. Erivan-ER 37.5 Tablet is a psychotropic medication; these medications affect the mind, emotions, and behavior.
No, Erivan-ER 37.5 Tablet is not a narcotic. Narcotics are opioid-derived drugs, such as heroin and morphine, that induce sleep.
Erivan-ER 37.5 Tablet and its XR formulation are identical extended-release medications. This slow release maintains consistent therapeutic drug levels, reducing the needed dosing frequency.
Mirtazapine and Erivan-ER 37.5 Tablet should not be taken together. This combination carries a significant risk of serotonin syndrome, a potentially life-threatening condition. Symptoms may include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma.
Combining citalopram and Erivan-ER 37.5mg tablets risks serotonin syndrome, a potentially fatal condition. Symptoms include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma. An alternative medication should be considered.
P-glycoprotein effluxes Erivan-ER 37.5 Tablet from the brain; however, some studies indicate that Erivan-ER 37.5 Tablet and its metabolite inhibit this transporter.
The liver metabolizes Erivan-ER 37.5 Tablet before its intestinal absorption.
Erivan-ER 37.5 Tablets are prescribed for generalized depressive disorder. Always consult your physician before use.
Some individuals taking Erivan-ER 37.5 Tablets experience persistent high blood pressure. Regular blood pressure monitoring is advised for these patients, with potential dose adjustment or treatment cessation if necessary.
Yes, Erivan-ER 37.5 Tablets can cause constipation. Increase your fiber intake and fluid consumption. Laxatives may also be helpful. Your doctor can advise on prevention and management. Consult your doctor if constipation persists or worsens.
Yes. Erivan-ER 37.5 Tablet has been associated with weight loss in some patients; studies show this effect increases with higher doses and prolonged use. Consult your doctor if this concerns you.
Erivan-ER 37.5 Tablets are not habit-forming.
Consult your doctor before substituting tablets for capsules. Altering your medication without professional guidance is risky, as different formulations affect drug release and may result in ineffective treatment, side effects, or treatment failure.
Yes, gabapentin can be combined with Erivan-ER 37.5 Tablet, but only under a doctor's supervision. Concurrent use may increase drowsiness, sleepiness, and impair concentration. Exercise caution.
Desvenlafaxine is the active ingredient in Erivan-ER 37.5 Tablet.
Erivan-ER 37.5 Tablet is not FDA-approved for fibromyalgia, although some studies suggest potential benefits. Consult your physician before using it for this condition.
Though not FDA-approved for nerve pain, Erivan-ER 37.5 Tablet shows efficacy in some research and is used off-label for this condition.
Erivan-ER 37.5 Tablets can alter brain neurotransmitter levels, resulting in dose-dependent appetite suppression.
Should you experience side effects such as reduced libido or erectile dysfunction, consult your doctor to discuss alternative treatment options. Do not discontinue Erivan-ER 37.5 Tablet without medical supervision, as this may worsen side effects.
Erivan-ER 37.5 Tablet
31
MRP 36
13% off